Insider Selling: Shattuck Labs, Inc. (NASDAQ:STTK) Director Sells $221,164.72 in Stock

Shattuck Labs, Inc. (NASDAQ:STTK) Director Josiah Hornblower sold 7,382 shares of the business’s stock in a transaction that occurred on Sunday, June 20th. The stock was sold at an average price of $29.96, for a total transaction of $221,164.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Josiah Hornblower also recently made the following trade(s):

  • On Friday, June 18th, Josiah Hornblower sold 9,840 shares of Shattuck Labs stock. The shares were sold at an average price of $29.00, for a total transaction of $285,360.00.
  • On Wednesday, June 16th, Josiah Hornblower sold 8,691 shares of Shattuck Labs stock. The shares were sold at an average price of $27.80, for a total transaction of $241,609.80.
  • On Monday, June 14th, Josiah Hornblower sold 5,356 shares of Shattuck Labs stock. The shares were sold at an average price of $29.05, for a total transaction of $155,591.80.
  • On Friday, June 11th, Josiah Hornblower sold 4,392 shares of Shattuck Labs stock. The shares were sold at an average price of $29.41, for a total transaction of $129,168.72.
  • On Wednesday, June 9th, Josiah Hornblower sold 7,601 shares of Shattuck Labs stock. The shares were sold at an average price of $29.21, for a total transaction of $222,025.21.
  • On Monday, June 7th, Josiah Hornblower sold 10,736 shares of Shattuck Labs stock. The shares were sold at an average price of $29.45, for a total transaction of $316,175.20.
  • On Thursday, June 3rd, Josiah Hornblower sold 17,824 shares of Shattuck Labs stock. The shares were sold at an average price of $27.46, for a total transaction of $489,447.04.
  • On Friday, May 28th, Josiah Hornblower sold 8,747 shares of Shattuck Labs stock. The shares were sold at an average price of $27.18, for a total transaction of $237,743.46.
  • On Wednesday, May 26th, Josiah Hornblower sold 5,320 shares of Shattuck Labs stock. The shares were sold at an average price of $24.74, for a total transaction of $131,616.80.
  • On Monday, May 24th, Josiah Hornblower sold 5,456 shares of Shattuck Labs stock. The shares were sold at an average price of $25.23, for a total transaction of $137,654.88.

STTK stock opened at $28.01 on Friday. The company has a market capitalization of $1.17 billion and a P/E ratio of -11.87. Shattuck Labs, Inc. has a 12 month low of $17.51 and a 12 month high of $60.52. The business has a 50 day simple moving average of $29.16.

Shattuck Labs (NASDAQ:STTK) last posted its earnings results on Monday, May 10th. The company reported ($0.28) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.39) by $0.11. The business had revenue of $2.27 million during the quarter. As a group, equities research analysts forecast that Shattuck Labs, Inc. will post -1.37 earnings per share for the current year.

A number of hedge funds have recently bought and sold shares of STTK. BlackRock Inc. bought a new stake in Shattuck Labs in the fourth quarter worth approximately $45,082,000. New York State Common Retirement Fund bought a new stake in Shattuck Labs in the fourth quarter worth approximately $535,000. Alliancebernstein L.P. bought a new stake in Shattuck Labs in the fourth quarter worth approximately $204,000. Bank of New York Mellon Corp bought a new stake in Shattuck Labs in the fourth quarter worth approximately $2,331,000. Finally, Clark Estates Inc. NY bought a new stake in Shattuck Labs in the fourth quarter worth approximately $41,908,000. 55.96% of the stock is owned by institutional investors.

A number of research analysts recently commented on STTK shares. Berenberg Bank started coverage on shares of Shattuck Labs in a research report on Wednesday, April 14th. They set a “buy” rating and a $47.00 price objective on the stock. Zacks Investment Research raised shares of Shattuck Labs from a “sell” rating to a “hold” rating in a research report on Tuesday, May 18th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $45.60.

About Shattuck Labs

Shattuck Labs, Inc, a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers.

Featured Story: What is the price-to-earnings growth (PEG) ratio?

Insider Buying and Selling by Quarter for Shattuck Labs (NASDAQ:STTK)

Receive News & Ratings for Shattuck Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shattuck Labs and related companies with MarketBeat.com's FREE daily email newsletter.